Elsevier

The Lancet

Volume 363, Issue 9405, 24 January 2004, Pages 292-294
The Lancet

Research Letters
Group B streptococcal disease in UK and Irish infants younger than 90 days

https://doi.org/10.1016/S0140-6736(03)15389-5Get rights and content

Summary

The incidence, morbidity, and mortality of group B streptococcal disease in the UK and Republic of Ireland are largely unknown. Between Feb 1, 2000, and Feb 28, 2001, we identified cases of invasive group B streptococcal disease in infants younger than 90 days through surveillance involving paediatricians, microbiologists, and parents. 568 cases were identified, equivalent to a total incidence of 0·72 per 1000 live-births (95% CI 0·66–0·78); the incidence for early-onset disease (n=377) was 0·48 per 1000 (0·43–0·53), and for late-onset disease (n=191) was 0·24 per 1000 (0·21–0·28). Risk factors were identifiable for 218 (58%) cases of early-onset disease. 53 infants died (overall 9·7%). We have established the minimum current burden of group B streptococcal disease in UK and Irish infants. This information will assist in the formulation of guidelines for prevention of this disease.

References (5)

There are more references available in the full text version of this article.

Cited by (221)

  • Impact of late-onset group B streptococcus infection on families: An observational study

    2021, European Journal of Obstetrics and Gynecology and Reproductive Biology
  • Group B streptococcal disease in the mother and newborn—A review

    2020, European Journal of Obstetrics and Gynecology and Reproductive Biology
View all citing articles on Scopus
View full text